Suppr超能文献

相似文献

2
New drugs and strategies for management of Clostridium difficile colitis.
J Intensive Care Med. 2014 Jul-Aug;29(4):190-9. doi: 10.1177/0885066613475426. Epub 2013 Feb 7.
3
The burden of Clostridium difficile in surgical patients in the United States.
Surg Infect (Larchmt). 2007 Dec;8(6):557-66. doi: 10.1089/sur.2006.062.
4
Overview of severe Clostridium difficile infection.
Crit Care Clin. 2013 Oct;29(4):827-39. doi: 10.1016/j.ccc.2013.06.004. Epub 2013 Aug 6.
5
Clostridium difficile colitis: A clinical review.
Am J Surg. 2017 Mar;213(3):565-571. doi: 10.1016/j.amjsurg.2016.10.035. Epub 2017 Jan 3.
6
Pathogenicity Locus, Core Genome, and Accessory Gene Contributions to Virulence.
mBio. 2017 Aug 8;8(4):e00885-17. doi: 10.1128/mBio.00885-17.
7
Clostridium difficile colitis in patients undergoing lumbar spine surgery.
Spine (Phila Pa 1976). 2014 Sep 1;39(19):E1167-73. doi: 10.1097/BRS.0000000000000487.
8
Clostridium difficile-associated disease and mortality among the elderly critically ill.
Crit Care Med. 2009 Sep;37(9):2583-9. doi: 10.1097/CCM.0b013e3181ab8388.
9
10
The growing incidence and severity of Clostridium difficile infection in inpatient and outpatient settings.
Expert Rev Gastroenterol Hepatol. 2010 Aug;4(4):409-16. doi: 10.1586/egh.10.48.

本文引用的文献

1
Exogenous phosphatidylcholine supplementation improves intestinal barrier defense against Clostridium difficile toxin.
J Trauma Acute Care Surg. 2014 Oct;77(4):570-5; discussion 576. doi: 10.1097/TA.0000000000000378.
2
The host immune response to Clostridium difficile infection.
Ther Adv Infect Dis. 2013 Feb;1(1):19-35. doi: 10.1177/2049936112472173.
4
Gut solutions to a gut problem: bacteriocins, probiotics and bacteriophage for control of Clostridium difficile infection.
J Med Microbiol. 2013 Sep;62(Pt 9):1369-1378. doi: 10.1099/jmm.0.058933-0. Epub 2013 May 22.
5
Mortality and Clostridium difficile infection: a review.
Antimicrob Resist Infect Control. 2012 May 30;1(1):20. doi: 10.1186/2047-2994-1-20.
6
Fecal microbiota transplantation for recurrent clostridium difficile infection.
J Clin Gastroenterol. 2011 Nov;45 Suppl:S159-67. doi: 10.1097/MCG.0b013e318222e603.
7
Increases in mortality, length of stay, and cost associated with hospital-acquired infections in trauma patients.
Arch Surg. 2011 Jul;146(7):794-801. doi: 10.1001/archsurg.2011.41. Epub 2011 Mar 21.
8
Fidaxomicin versus vancomycin for Clostridium difficile infection.
N Engl J Med. 2011 Feb 3;364(5):422-31. doi: 10.1056/NEJMoa0910812.
9
Pathogenic C difficile is here (and everywhere) to stay.
Lancet. 2011 Jan 1;377(9759):8-9. doi: 10.1016/S0140-6736(10)61885-5.
10
Durable alteration of the colonic microbiota by the administration of donor fecal flora.
J Clin Gastroenterol. 2010 Sep;44(8):551-61. doi: 10.1097/MCG.0b013e3181e5d06b.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验